Hilmar Wisplinghoff

12.7k total citations · 2 hit papers
97 papers, 8.7k citations indexed

About

Hilmar Wisplinghoff is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Hilmar Wisplinghoff has authored 97 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 41 papers in Epidemiology and 21 papers in Molecular Medicine. Recurrent topics in Hilmar Wisplinghoff's work include Antifungal resistance and susceptibility (27 papers), Antibiotic Resistance in Bacteria (21 papers) and Bacterial Identification and Susceptibility Testing (19 papers). Hilmar Wisplinghoff is often cited by papers focused on Antifungal resistance and susceptibility (27 papers), Antibiotic Resistance in Bacteria (21 papers) and Bacterial Identification and Susceptibility Testing (19 papers). Hilmar Wisplinghoff collaborates with scholars based in Germany, United States and Spain. Hilmar Wisplinghoff's co-authors include Harald Seifert, Michael B. Edmond, Richard P. Wenzel, Sandra Tallent, Thomas Bischoff, Paul G. Higgins, Danuta Stefanik, Oliver A. Cornely, Sergio G. Bartual and Francisco Rodríguez‐Valera and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Hilmar Wisplinghoff

95 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

2004 3.5k citations Hilmar Wisplinghoff, Harald Seifert et al. Clinical Infectious Diseases profile →
Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii

2005 530 citations Sergio G. Bartual, Harald Seifert et al. Journal of Clinical Microbiology profile →

Peers

Countries citing papers authored by Hilmar Wisplinghoff

Since Specialization

Citations

This map shows the geographic impact of Hilmar Wisplinghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilmar Wisplinghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilmar Wisplinghoff more than expected).

Fields of papers citing papers by Hilmar Wisplinghoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilmar Wisplinghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilmar Wisplinghoff. The network helps show where Hilmar Wisplinghoff may publish in the future.

Co-authorship network of co-authors of Hilmar Wisplinghoff

This figure shows the co-authorship network connecting the top 25 collaborators of Hilmar Wisplinghoff. A scholar is included among the top collaborators of Hilmar Wisplinghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilmar Wisplinghoff. Hilmar Wisplinghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of novel antimicrobial blue light-emitting optical fiber on vancomycin-resistant Enterococcus faecium and carbapenemase-producing Klebsiella pneumoniae 2025 ·Journal of Bone and Joint Infection ·(unknown), Barbara Körber-Irrgang, (unknown), (unknown), Hilmar Wisplinghoff, Antonia F. Chen, Nathalie Jazmati, Santiago A. Lozano‐Calderón	0
2	Performance evaluation of the Specific Reveal system for rapid antibiotic susceptibility testing from positive blood cultures containing Gram-negative pathogens 2024 ·Journal of Clinical Microbiology ·(unknown), Barbara Körber-Irrgang, (unknown), (unknown), Kim Chi Vo, (unknown), Ute Aurbach, Hilmar Wisplinghoff, Nathalie Jazmati	3
3	The tongue microbiome of young patients with chronic kidney disease and their healthy mothers 2024 ·Clinical Oral Investigations ·(unknown), Lutz T. Weber, Anna Greta Barbe, (unknown), (unknown), Angela Nowag, Claus Jürgen Scholz, Hilmar Wisplinghoff, Michael Noack, Nathalie Jazmati	3
4	Semitendinosus tendons are commonly contaminated with skin flora during graft harvest for anterior cruciate ligament reconstruction 2023 ·Knee Surgery Sports Traumatology Arthroscopy ·Christoph Offerhaus, Vera Jaecker, Sven Shafizadeh, (unknown), (unknown), Hilmar Wisplinghoff, Nathalie Jazmati	5
5	Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease 2021 ·Liver International ·Sonja Lang, Anna Martin, Xinlian Zhang, Fedja Farowski, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild, Marcin Krawczyk, Angela Nowag, (unknown), Claus Jürgen Scholz, Philipp Kasper, Christoph Roderburg, Raphael Mohr, Frank Lammert, Frank Tacke, Bernd Schnabl, Tobias Goeser, Hans‐Michael Steffen, Münevver Demir	22
6	SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response 2021 ·Frontiers in Medicine ·Lisa Müller, Marcel Andrée, Philipp Niklas Ostermann, Nathalie Jazmati, (unknown), Johannes Fischer, Edwin Bölke, Eva Heger, Kanika Vanshylla, Florian Klein, Hilmar Wisplinghoff, Heiner Schaal, Ingo Drexler, Andreas Walker, Ortwin Adams, Jörg Timm	8
7	Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis 2019 ·Clinical Microbiology and Infection ·Philipp Koehler, Melanie Stecher, Oliver A. Cornely, Daniela Koehler, Maria J. G. T. Vehreschild, Julia Bohlius, Hilmar Wisplinghoff, Jörg Janne Vehreschild	204
8	Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·Sibylle C. Mellinghoff, Pia Hartmann, (unknown), (unknown), (unknown), Philipp Köhler, (unknown), (unknown), (unknown), Vidya Menon, (unknown), Jan‐Hendrik Naendrup, (unknown), (unknown), (unknown), Danila Seidel, Hilmar Wisplinghoff, Oliver A. Cornely	31
9	FungiScope^™—Global Emerging Fungal Infection Registry 2017 ·Mycoses ·Danila Seidel, Luisa Durán Graeff, Maria J. G. T. Vehreschild, Hilmar Wisplinghoff, Maren Ziegler, Jörg Janne Vehreschild, Blasius Liss, Axel Hamprecht, Philipp Köhler, Zdeněk Ráčil, Н Н Климко, Donald C. Sheppard, Raoul Herbrecht, Anuradha Chowdhary, Oliver A. Cornely, (unknown)	31
10	Candida reactive T cells for diagnosis of invasive Candida infection 2017 ·Mycoses ·(unknown), Oliver A. Cornely, Hilmar Wisplinghoff, Astrid Schauß, (unknown), (unknown), (unknown), Helmut Ostermann, (unknown)	1
11	Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates 2016 ·PLoS ONE ·(unknown), Paul G. Higgins, Danuta Stefanik, Hilmar Wisplinghoff, Harald Seifert	69
12	1,3‐ß‐D‐glucan concentrations in blood products predict false positive post‐transfusion results 2015 ·Mycoses ·Blasius Liss, Oliver A. Cornely, Dennis Hoffmann, (unknown), Hilmar Wisplinghoff	21
13	Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis 2014 ·Biology of Blood and Marrow Transplantation ·Maria J. G. T. Vehreschild, (unknown), Lena M. Biehl, Daniela Tacke, Dirk Waldschmidt, Ulrich Töx, Hilmar Wisplinghoff, Michael von Bergwelt‐Baildon, Oliver A. Cornely, Jörg Janne Vehreschild	43
14	RIG-I Detects Triphosphorylated RNA of Listeria monocytogenes during Infection in Non-Immune Cells 2013 ·PLoS ONE ·(unknown), (unknown), Zeinab Abdullah, Thomas Zillinger, Christopher Jakobs, (unknown), Christoph Coch, Paul G. Higgins, Hilmar Wisplinghoff, Winfried Barchet, Veit Hornung, Gunther Hartmann, Martin Schlee	62
15	Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients 2011 ·Epidemiology and Infection ·Jörg Janne Vehreschild, Paul J. Bröckelmann, Christopher Bangard, Jens Verheyen, Maria J. G. T. Vehreschild, G. Michels, Hilmar Wisplinghoff, Oliver A. Cornely	23
16	Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme 2008 ·Clinical Microbiology and Infection ·Hilmar Wisplinghoff, (unknown), Sergio G. Bartual, (unknown), Danuta Stefanik, Paul G. Higgins, Harald Seifert	52
17	A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU 2007 ·Clinical Microbiology and Infection ·Paul G. Higgins, Hilmar Wisplinghoff, Oleg Krut, Harald Seifert	116
18	Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii breakdown → 2005 ·Journal of Clinical Microbiology ·Sergio G. Bartual, Harald Seifert, (unknown), (unknown), Hilmar Wisplinghoff, Francisco Rodríguez‐Valera	530
19	Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates 2003 ·Journal of Clinical Microbiology ·Hilmar Wisplinghoff	9
20	Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility 2000 ·Clinical Infectious Diseases ·Hilmar Wisplinghoff, Michael B. Edmond, Michael A. Pfaller, Ronald N. Jones, Richard P. Wenzel, Harald Seifert	181

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact